Menu Search
Equities

TenX Keane Acquisition

TENK:NMQ

TenX Keane Acquisition

Actions
  • Price (USD)11.33
  • Today's Change0.00 / 0.00%
  • Shares traded1.00
  • 1 Year change+8.42%
  • Beta--
Data delayed at least 15 minutes, as of May 23 2024 20:18 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		TENK:NMQ since
announced		Transaction
value
Citius Oncology IncAnnounced24 Oct 202324 Oct 2023Announced4.52%675.00m
Data delayed at least 15 minutes, as of May 23 2024 20:18 BST.

Institutional shareholders

54.83%Per cent of shares held by top holders
HolderShares% Held
W.R. Berkley Corp. (Investment Portfolio)as of 31 Mar 2024530.30k7.97%
Cowen & Co. LLCas of 31 Mar 2024514.51k7.73%
Wolverine Asset Management LLCas of 31 Mar 2024412.55k6.20%
First Trust Capital Management LPas of 31 Mar 2024373.81k5.62%
RiverNorth Capital Management LLCas of 31 Mar 2024350.00k5.26%
Mizuho Securities USA LLCas of 31 Mar 2024331.00k4.98%
Glazer Capital LLCas of 31 Mar 2024311.29k4.68%
Westchester Capital Management LLCas of 31 Mar 2024300.00k4.51%
Hudson Bay Capital Management LPas of 31 Mar 2024299.30k4.50%
Yakira Capital Management, Inc.as of 31 Mar 2024225.00k3.38%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.